Overexpression of HER-2 in MDA-MB-435/LCC6 Tumours is Associated with Higher Metabolic Activity and Lower Energy Stress
Wieslawa H. Dragowska(BC Cancer Agency), Donald T. Yapp(Canada's Michael Smith Genome Sciences Centre)
Cited by 1
Related Papers
Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer
|PLoS ONE|2013|101
The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity
|BMC Cancer|2011|28
Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo
|Pharmaceutics|2024|4